More than 1,000 patients have been treated with Dermagraft in studies of various indications, including burns, venous ulcers, pressure ulcers, and diabetic ulcers. Dermagraft has been commercially available in many countries for more than 5 years. Since its approval in 2001, Dermagraft has been used on more than 15,000 patients with diabetic foot ulcers.

That decision rests with individual physicians. Experience has shown that the vast majority of patients with superficial venous reflux disease can be treated with the Closure procedure.

Dermagraft is a cryopreserved human fibroblast-derived dermal substitute; it is composed of fibroblasts, extracellular matrix, and a bioabsorbable scaffold.

A limited number of patients have been implanted with the device in early clinical trials to evaluate the safety and effectiveness of the device in patients with end-stage AMD. Clinical results have been reported to the F.D.A. to support conducting the initiation of this larger trial of approximately 200 patients.

No. You will see new packaging design, but otherwise Dermagraft will remain the same high quality product it has always been.

Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than 6 weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Dermagraft should be used in conjunction with standard wound care regimens and in patients who have adequate blood supply to the involved foot.

Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. During the manufacturing process, the human fibroblasts are seeded onto a bioabsorbable polyglactin mesh scaffold. The fibroblasts proliferate to fill the interstices of this scaffold and secrete human dermal collagen, matrix proteins, growth factors, and cytokines to create a three-dimensional human dermal substitute containing metabolically active living cells.

The safety of Dermagraft is assured through extensive testing. The proprietary freezing process (cryopreservation) allows for storage of the product while safety testing is conducted, to assure the product passes extensive safety requirements before shipment.

In a randomized controlled clinical trial, Dermagraft healed more chronic* ulcers and healed them faster than conventional therapy alone.

Dermagraft is supplied frozen in a clear bag containing one piece of approximately 2” x 3” (5 cm x 7.5 cm) for a single-use application.

No. All patients in acute care facilities would be equally subject to ventilator triage guidelines, regardless of their disease category or role in the community.

Over two hundred patients at fifty sites received an Optimizer device in the United States . Outside the US (Europe and Hong Kong), approximately 210 patients received an Optimizer device. Some patients have already received more than three years of treatment.

In some cases it is the decision of the guardian of the child and the physician as to whether the child is mature enough to make decisions regarding their health without the influence or presence of their parents. Some physicians may require that a document be signed in various situations. Talk to your doctor for more information about their policy.

In clinical trials, TRELSTAR produced a transient surge in testosterone levels [1,2] that peaked on days 2–3 with TRELSTAR LA and on day 4 with TRELSTAR Depot. TRELSTAR LA and Depot reduced serum testosterone concentrations below castrate levels [1,2]. In addition, >94% of all patients maintained castrate levels from month 2 through month 9.

We maintain a list of former patients that have volunteered to speak with new and prospective patients of the Gerson Therapy. Names from this list are available to anyone seriously interested in undertaking the Therapy. Any one of our client service representatives can assist you with getting the name and number of a volunteer networker relative to your case or situation. Call 1-888-443-7766

Thousands of men have chosen cryo to treat prostate cancer. This therapy, first introduced in the 1960s, has seen dramatic improvements during the past eight years with the use of temperature monitoring, argon-based cryogen and ultrasound guidance techniques. The temperature monitoring and ultrasound visualization used in targeted cryotherapy allow the physician to precisely freeze the prostate gland while sparing other critical areas of surrounding tissue.

Since the device was approved for use in Europe at the end of 1998, more than 400 patients have used the Meniett device, including individuals participating in clinical studies with the device.

Currently, doctors are treating more than 100,000 patients and the number grows daily. Align Technology's proprietary treatment planning software is available in English, German, French, Spanish, and Italian. Patients are being treated with Invisalign throughout Europe, Japan, Australia, Israel, Colombia, Brazil, Mexico, Canada, and elsewhere. For the periods January 2001 to February 2002 and January 2002 to February 2003, Dr.

No. Treatments are varied based on a patient's injuries and conditions. Chiropractic treatments are no more identical for each patient than other medical doctor's treatments are the same for each patient.

The MVZ treats patients insured by all the statutory health insurance companies and professional trade associations (for occupational accidents) as well as privately insured patients and those who wish to pay their own fees.

We have found that when the age exceeds 75, they do not respond to nature cure treatment because of old eating and irregular habits and also due to body condition. Hence, we discourage people above 75 except lovers of naturopathy, who are also extraordinarily fit.

When implanted into an adequately prepared diabetic foot ulcer, Dermagraft assists in the restoration of the dermal bed allowing the patient’s wound to heal (re-epithelialize).

Be aware that many of our patients have seen multiple physicians in the past. These patients may have a complicated history and may have failed previous treatments. Therefore, and individualized approach is used. For example, those patients who may present taking multiple narcotics are asked to choose a single narcotic as well as sign a narcotic agreement which allows us to be the sole provider of their pain medications.

No. The immunity created by Contre-Vir? is expected to be life-long and no repeat infection is likely from all the known sub-types of the HIV virus.

Clinical studies with TRELSTAR have demonstrated a durable reduction in prostate-specific antigen (PSA) levels. Specifically, PSA levels were reduced by 97% through month 9 [3,4]

A trial of light therapy should last at lease two to four weeks. A trial of antidepressants should last at least six weeks. Relapse generally occurs rapidly when light therapy is discontinued, and less rapidly when antidepressants are stopped. Most patients are treated only during the symptomatic winter months, and then discontinue their treatments during the spring and summer. The treatments are then restarted in the autumn.

Treatment of hypertension can be achieved through non-pharmacologic and pharmacologic means. It consists of the following: